Prognostic and Predictive Value of Tumor-Infiltrating Immune Cells in Urothelial Cancer of the Bladder

The prognosis and responsiveness to chemotherapy and checkpoint inhibitors differs substantially among patients with bladder cancer (BC). There is an unmet need for biomarkers that can accurately predict prognosis and treatment outcome. Here, we describe the available literature on the prognostic an...

Full description

Bibliographic Details
Main Authors: Sandra van Wilpe, Eveline C. F. Gerretsen, Antoine G. van der Heijden, I. Jolanda M. de Vries, Winald R. Gerritsen, Niven Mehra
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/9/2692
_version_ 1797553135156199424
author Sandra van Wilpe
Eveline C. F. Gerretsen
Antoine G. van der Heijden
I. Jolanda M. de Vries
Winald R. Gerritsen
Niven Mehra
author_facet Sandra van Wilpe
Eveline C. F. Gerretsen
Antoine G. van der Heijden
I. Jolanda M. de Vries
Winald R. Gerritsen
Niven Mehra
author_sort Sandra van Wilpe
collection DOAJ
description The prognosis and responsiveness to chemotherapy and checkpoint inhibitors differs substantially among patients with bladder cancer (BC). There is an unmet need for biomarkers that can accurately predict prognosis and treatment outcome. Here, we describe the available literature on the prognostic and predictive value of tumor-infiltrating immune cells in BC. Current evidence indicates that a high density of tumor-infiltrating CD8<sup>+</sup> T cells is a favorable prognostic factor, whereas PD-L1 expression and tumor-associated macrophages are unfavorable prognostic features. While PD-L1 expression appears unsuccessful as a biomarker for the response to checkpoint inhibitors, there are some indications that high CD8<sup>+</sup> T cell infiltration, low transforming growth factor-beta signaling and low densities of myeloid-derived suppressor cells are associated with response. Future studies should focus on combinations of biomarkers to accurately predict survival and response to treatment.
first_indexed 2024-03-10T16:11:07Z
format Article
id doaj.art-e031a05d7b7049b4afe10d85615549d5
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T16:11:07Z
publishDate 2020-09-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-e031a05d7b7049b4afe10d85615549d52023-11-20T14:29:53ZengMDPI AGCancers2072-66942020-09-01129269210.3390/cancers12092692Prognostic and Predictive Value of Tumor-Infiltrating Immune Cells in Urothelial Cancer of the BladderSandra van Wilpe0Eveline C. F. Gerretsen1Antoine G. van der Heijden2I. Jolanda M. de Vries3Winald R. Gerritsen4Niven Mehra5Department of Medical Oncology, the Radboud University Medical Center, 6525 GA Nijmegen, The NetherlandsDepartment of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The NetherlandsDepartment of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The NetherlandsDepartment of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The NetherlandsDepartment of Medical Oncology, the Radboud University Medical Center, 6525 GA Nijmegen, The NetherlandsDepartment of Medical Oncology, the Radboud University Medical Center, 6525 GA Nijmegen, The NetherlandsThe prognosis and responsiveness to chemotherapy and checkpoint inhibitors differs substantially among patients with bladder cancer (BC). There is an unmet need for biomarkers that can accurately predict prognosis and treatment outcome. Here, we describe the available literature on the prognostic and predictive value of tumor-infiltrating immune cells in BC. Current evidence indicates that a high density of tumor-infiltrating CD8<sup>+</sup> T cells is a favorable prognostic factor, whereas PD-L1 expression and tumor-associated macrophages are unfavorable prognostic features. While PD-L1 expression appears unsuccessful as a biomarker for the response to checkpoint inhibitors, there are some indications that high CD8<sup>+</sup> T cell infiltration, low transforming growth factor-beta signaling and low densities of myeloid-derived suppressor cells are associated with response. Future studies should focus on combinations of biomarkers to accurately predict survival and response to treatment.https://www.mdpi.com/2072-6694/12/9/2692urothelial cancerprognosisbiomarkerscheckpoint inhibitorschemotherapy
spellingShingle Sandra van Wilpe
Eveline C. F. Gerretsen
Antoine G. van der Heijden
I. Jolanda M. de Vries
Winald R. Gerritsen
Niven Mehra
Prognostic and Predictive Value of Tumor-Infiltrating Immune Cells in Urothelial Cancer of the Bladder
Cancers
urothelial cancer
prognosis
biomarkers
checkpoint inhibitors
chemotherapy
title Prognostic and Predictive Value of Tumor-Infiltrating Immune Cells in Urothelial Cancer of the Bladder
title_full Prognostic and Predictive Value of Tumor-Infiltrating Immune Cells in Urothelial Cancer of the Bladder
title_fullStr Prognostic and Predictive Value of Tumor-Infiltrating Immune Cells in Urothelial Cancer of the Bladder
title_full_unstemmed Prognostic and Predictive Value of Tumor-Infiltrating Immune Cells in Urothelial Cancer of the Bladder
title_short Prognostic and Predictive Value of Tumor-Infiltrating Immune Cells in Urothelial Cancer of the Bladder
title_sort prognostic and predictive value of tumor infiltrating immune cells in urothelial cancer of the bladder
topic urothelial cancer
prognosis
biomarkers
checkpoint inhibitors
chemotherapy
url https://www.mdpi.com/2072-6694/12/9/2692
work_keys_str_mv AT sandravanwilpe prognosticandpredictivevalueoftumorinfiltratingimmunecellsinurothelialcancerofthebladder
AT evelinecfgerretsen prognosticandpredictivevalueoftumorinfiltratingimmunecellsinurothelialcancerofthebladder
AT antoinegvanderheijden prognosticandpredictivevalueoftumorinfiltratingimmunecellsinurothelialcancerofthebladder
AT ijolandamdevries prognosticandpredictivevalueoftumorinfiltratingimmunecellsinurothelialcancerofthebladder
AT winaldrgerritsen prognosticandpredictivevalueoftumorinfiltratingimmunecellsinurothelialcancerofthebladder
AT nivenmehra prognosticandpredictivevalueoftumorinfiltratingimmunecellsinurothelialcancerofthebladder